Thyrocare Technologies Limited

BSE: 539871 NSE: THYROCARE
Thyrocare Technologies Limited - healthcare in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L85110MH2000PLC123882 Incorporated 28 January 2000 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Listed - NSE: THYROCARE · BSE: 539871 Public Limited Company healthcare
Data last updated
Market Cap
₹9,021 Cr
THYROCARE · NSE
Share Price
₹566.85
+0.02% today
Revenue
₹829 Cr
FY 2025-26 · +14.9% YoY
EBITDA
₹257 Cr
Margin 31.0%
Net Profit
₹161 Cr
FY 2025-26 · +85.5% YoY
P/E (TTM)
50.5x
P/B 17.8x
ROE
28.8%
ROCE 35.4%
Debt / Equity
0.07
Interest cover 2.0x

About Thyrocare Technologies Limited

Data last updated: 25 September 2026

Thyrocare Technologies Limited is a public limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Docon Technologies Private Limited. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 28 January 2000, the company has been in operation for over 26 years.

Registered with ROC Mumbai under CIN L85110MH2000PLC123882. Listed on BSE: 539871 and NSE: THYROCARE.

Capital: an authorised share capital of ₹300 Cr and a paid-up capital of ₹159.17 Cr. It is led by directors including Rahul Franklin Guha and Indumati Gopinathan.

Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: D37/1 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹829.04 Cr, a growth of 20.61% compared to the previous year. The net worth stands at ₹585.5 Cr (up 7.09% YoY). Total assets are valued at ₹648.82 Cr (up 12.12% YoY).

The company has a workforce of approximately 1,758 employees as per the latest available data. It operates as a subsidiary of Docon Technologies Private Limited. Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Healthcareontime, Thyrocare. As per MCA filings, the company has satisfied charges of ₹45.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thyrocare.com.

Company Details of Thyrocare Technologies Limited
CIN L85110MH2000PLC123882
Registration Number 123882
Incorporation Date 28 January 2000
ROC Mumbai
Listing Status Listed (BSE: 539871, NSE: THYROCARE)
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Docon Technologies Private Limited
Compliance Status Active Compliant
Key People
Rahul Franklin Guha Managing Director Indumati Gopinathan Director Nishant Amilal Shah Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    thyrocare.com
  • Social Media
  • Apps
  • Registered Address
    D37/1 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Thyrocare Technologies Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Thyrocare Technologies Limited report

Financials, compliance, directors, charges, ownership and filings for Thyrocare Technologies Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Thyrocare Technologies Limited

Thyrocare Technologies Limited has one previous CIN (Corporate Identification Number): U85110MH2000PLC123882. The current CIN is L85110MH2000PLC123882, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L85110MH2000PLC123882 Current
U85110MH2000PLC123882 Previous

Associated Brands with Thyrocare Technologies Limited

Thyrocare Technologies Limited operates two associated brands: HealthcareOnTime and Thyrocare. These brands represent Thyrocare Technologies Limited's diversified market presence and brand portfolio.

Brand Description Website
Thyrocare
Diagnostic testing centers for pathology and health screenings are operated. thyrocare.com
HealthcareOnTime
HealthcareOnTime provides online diagnostic and at-home health testing services in India. healthcareontime.com

Competitors & Alternatives of Thyrocare Technologies Limited

Brands and companies operating in the same space as Thyrocare Technologies Limited include Krsnaa Diagnostics, Suraksha Diagnostics, Vijaya Diagnostic Centre and 6 more.

Competitor Description Location Founded
Krsnaa Diagnostics Krsnaa Diagnostics Chain of radiology & pathology laboratory centers Pune, India, India 2011
Suraksha Diagnostics Suraksha Diagnostics Pathology, molecular diagnostics, and imaging services are provided. Kolkata, India, India 2005
Vijaya Diagnostic Centre Vijaya Diagnostic Centre Diagnostic services are offered via a chain of centers. Hyderabad, India, India 1981
Igenetic Igenetic Provider molecular diagnostic solutions and services Mumbai, India, India 2013
PH Diagnostic Centre PH Diagnostic Centre Provider of medical diagnostic services including blood tests, urine tests, and specialized health check-ups Pune, India, India 2001
GD GD A chain of clinical laboratories is operated for diagnostic services. Mumbai, India, India 2007
Aarthi Scans Aarthi Scans Chain of diagnostic centers Chennai, India, India 2000
Primex Healthcare and Research Primex Healthcare and Research A chain of pathology and imaging labs is operated. Chennai, India, India 2010
Medall Medall Medical diagnostic services are provided through a chain of centres. Chennai, India, India 2008

Business Activity of Thyrocare Technologies Limited

Thyrocare Technologies Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q2 Medical and dental practice, Nursing, pathology, blood bank services, etc. Locked
Premium access

Business activity turnover details for Thyrocare Technologies Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Thyrocare Technologies Limited

Thyrocare Technologies Limited is audited by MSKA & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MSKA & Associates Locked Locked Locked
Premium access

Complete auditor history for Thyrocare Technologies Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Thyrocare Technologies Limited

Thyrocare Technologies Limited is currently managed by 9 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rahul Franklin Guha
Also directs: Thyrocare Technologies Limited, Api Holdings Limited, Nueclear Healthcare Limited
Managing Director 03 Aug 2022 4 Years 1 Months Current
Indumati Gopinathan
Also directs: Thyrocare Technologies Limited, Rashi Peripherals Limited
Director 12 Aug 2017 9 Years 1 Months Current
Nishant Amilal Shah
Also directs: Thyrocare Technologies Limited, Nueclear Healthcare Limited, Jackstien International Llp and 2 more
Director 15 Jun 2024 2 Years 3 Months Current
Anandh Sundar
Also directs: Thyrocare Technologies Limited, Nueclear Healthcare Limited, Cera Sanitaryware Limited and 3 more
Director 15 Jun 2024 2 Years 3 Months Current
Alok Kumar Jagnani
Also directs: Pulse Hitech Health Services (Ghatkopar) Llp, Thyrocare Technologies Limited, Venkatesh Medico Private Limited and 4 more
Director 24 Jul 2025 1 Years 2 Months Current
Harshil Jiten Vora
Also directs: Thyrocare Technologies Limited
Director 14 Jul 2023 3 Years 2 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Thyrocare Technologies Limited FY 2025-26 filings available

Thyrocare Technologies Limited reported revenue of ₹829.04 Cr (up 20.61% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹829 Cr
+20.6% YoY
EBITDA
₹257 Cr
+35.6% YoY
Profit After Tax
₹161 Cr
+85.5% YoY
Net Worth
₹586 Cr
+7.1% YoY
Total Assets
₹649 Cr
+12.1% YoY
Total Debt
₹50.69 Cr
+105.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue829687572527589495434
Revenue growth+14.9%+14.9%+7.2%+14.4%+9.2%+21.0%+7.5%
EBITDA257190139123236171167
EBITDA margin+31.0%+27.6%+24.3%+23.3%+40.0%+34.6%+38.5%
Profit before tax21314595.9888.59228152140
Net profit16186.6971.3964.2115810889.53
Net profit margin+19.4%+12.6%+12.5%+12.2%+26.8%+21.8%+20.6%
EPS (₹)10.2417.2713.3612.1833.3021.4016.73
Balance sheet
Total assets649579573562548449387
Net worth586547527534527427367
Total debt50.6924.6842.3423.3120.708.4912.44
Cash & bank68.1654.4839.8928.4713.9115.7311.07
Net working capital12286.2870.9180.7385.2943.895.52
Cash flow
Cash from operations213191168129113115168
Cash from investing(23.00)(52.52)(91.29)(38.99)(23.57)(48.66)0.95
Cash from financing(170)(130)(84.81)(86.18)(89.41)(61.58)(165)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue240224196217193187166177
Revenue growth (YoY)+24.3%+19.7%+17.9%+22.1%+23.0%+21.3%+23.1%+19.8%
Other income4.864.895.263.334.904.594.012.61
EBITDA77.2775.0951.6771.3557.7757.0741.5748.00
EBITDA margin+32.2%+33.5%+26.4%+33.0%+29.9%+30.5%+25.1%+27.1%
Depreciation12.4914.0321.6311.5111.4113.7717.0613.07
Interest1.351.52(0.09)0.590.780.700.600.76
Profit before tax68.2964.4335.3962.5850.4847.1927.9236.78
Tax16.9615.737.3414.7712.1925.628.9710.36
Net profit51.3348.7028.0547.8138.2921.5718.9526.42
EPS (₹)3.222.981.819.037.334.173.564.99
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue774633524486562474401
Revenue growth+17.4%+14.6%+4.5%+12.8%+8.7%+9.3%+25.0%
EBITDA251188135114232171123
EBITDA margin+32.5%+29.6%+25.8%+23.5%+41.2%+36.0%+30.8%
Profit before tax21015198.2281.07207161112
Net profit14791.4268.8455.24149114104
Net profit margin+19.0%+14.4%+13.1%+11.4%+26.5%+24.1%+25.9%
EPS (₹)9.3518.0813.4410.7628.7422.6515.01
Balance sheet
Total assets626572560547542469395
Net worth561537514521521445378
Total debt48.1823.2138.8221.1721.439.639.20
Cash & bank62.6351.9834.1016.3912.007.677.30
Net working capital12390.1470.6268.8487.1019.77(2.46)
Cash flow
Cash from operations206179155120106111136
Cash from investing(20.92)(42.58)(80.29)(31.65)(12.32)(53.09)26.84
Cash from financing(167)(124)(83.71)(87.50)(86.91)(57.81)(163)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue226211182202179174153163
Revenue growth (YoY)+26.1%+21.2%+19.6%+24.0%+24.6%+23.1%+24.1%+19.6%
Other income3.513.723.432.283.964.543.512.12
Total expenses150138130133122118112114
EBITDA75.6172.6352.3068.9156.5255.6440.2548.79
EBITDA margin+33.5%+34.5%+28.7%+34.1%+31.6%+32.0%+26.4%+29.9%
Depreciation11.2312.9419.589.708.9511.7815.349.94
Interest1.261.43(0.47)0.600.620.600.480.63
Profit before tax66.6361.9836.6260.8950.9147.8027.9440.34
Tax16.4618.4010.4717.8614.8625.858.8410.75

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 25 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue240224196217193187166177
Revenue growth (YoY)+24.3%+19.7%+17.9%+22.1%+23.0%+21.3%+23.1%+19.8%
Other income4.864.895.263.334.904.594.012.61
EBITDA77.2775.0951.6771.3557.7757.0741.5748.00
EBITDA margin+32.2%+33.5%+26.4%+33.0%+29.9%+30.5%+25.1%+27.1%
Depreciation12.4914.0321.6311.5111.4113.7717.0613.07
Interest1.351.52(0.09)0.590.780.700.600.76
Profit before tax68.2964.4335.3962.5850.4847.1927.9236.78
Tax16.9615.737.3414.7712.1925.628.9710.36
Net profit51.3348.7028.0547.8138.2921.5718.9526.42
EPS (₹)3.222.981.819.037.334.173.564.99
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue829687572527589495434
Revenue growth+14.9%+14.9%+7.2%+14.4%+9.2%+21.0%+7.5%
Other income18.3814.839.769.6029.2512.437.18
Total expenses572498433404353323267
Employee cost13812710810661.1358.0748.92
EBITDA257190139123236171167
EBITDA margin+31.0%+27.6%+24.3%+23.3%+40.0%+34.6%+38.5%
Depreciation58.5855.2647.0138.7133.8730.2831.91
Interest3.963.745.534.833.210.871.85
Profit before tax21314595.9888.59228152140
Tax50.0354.6926.4924.2351.5839.3252.01
Net profit16186.6971.3964.2115810889.53
Net profit margin+19.4%+12.6%+12.5%+12.2%+26.8%+21.8%+20.6%
EPS (₹)10.2417.2713.3612.1833.3021.4016.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital15952.9952.9552.9352.9052.8752.84
Reserves & surplus354439440462474374314
Shareholders' funds (net worth)586547527534527427367
Minority interest0.520.300.860.920.000.000.00
Secured loans0.000.0028.630.000.000.000.00
Unsecured loans50.6924.6813.7123.3120.708.4912.44
Total debt50.6924.6842.3423.3120.708.4912.44
Total liabilities649579573562548449387
Assets
Gross block601543501461423366359
Net block317297306294285253269
Capital work in progress3.0714.152.551.612.958.284.93
Investments17716216214414612690.20
Inventories48.4646.5447.5227.6724.5323.3620.62
Sundry debtors73.8873.0043.4785.1293.2044.6816.30
Cash & bank balances68.1654.4839.8928.4713.9115.7311.07
Loans & advances30.2926.3410.889.3813.1752.1834.97
Total current assets22120014215114513682.96
Total current liabilities98.4011470.8569.9159.5292.0677.44
Net working capital12286.2870.9180.7385.2943.895.52
Total assets649579573562548449387
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash17.689.3017.7713.6313.208.714.91
Net cash from operating activities213191168129113115168
Net cash from investing activities(23.00)(52.52)(91.29)(38.99)(23.57)(48.66)0.95
Net cash from financing activities(170)(130)(84.81)(86.18)(89.41)(61.58)(165)
Net change in cash20.648.38(8.47)4.140.434.494.05
Closing cash68.1654.4839.8928.4713.9115.7311.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+20.6%+20.2%+8.6%-10.6%+19.1%+13.9%+7.8%
EBITDA growth+35.6%+36.7%+13.3%-48.0%+37.6%+2.5%+8.3%
PBT growth+46.4%+51.5%+8.3%-61.1%+49.4%+8.6%+1.7%
Net income growth+85.5%+21.4%+11.2%-59.3%+46.5%+20.1%+9.3%
Revenue CAGR (3Y)+16.3%+5.3%+5.0%+6.6%+13.5%+11.6%+12.6%
EBITDA CAGR (3Y)+28.0%-7.0%-6.8%-9.8%+15.2%+6.3%+23.8%
Profitability & leverage
Net income margin+19.6%+13.2%+12.2%+12.2%+29.9%+22.9%+20.4%
Return on capital employed+35.4%+25.9%+17.9%+16.9%+41.4%+36.7%+33.8%
Return on net worth+28.8%+16.9%+13.1%+12.1%+33.1%+28.5%+22.1%
Debt / equity0.070.060.060.040.030.030.02
Long-term debt / equity0.050.040.040.030.020.020.01
Interest cover2.002.786.035.761.590.621.37
Efficiency & per share
Fixed asset turnover1.451.321.191.191.491.361.22
Inventory turnover17.4514.6215.2120.1824.5922.4922.44
Debtors turnover11.2911.808.895.918.5416.2230.52
EPS (₹)10.2417.2713.3612.1833.3021.4016.73
Dividend per share (₹)14.0021.0018.0018.0015.0025.005.00
Book value per share (₹)32.2192.8193.0397.3799.5480.8269.39
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue226211182202179174153163
Revenue growth (YoY)+26.1%+21.2%+19.6%+24.0%+24.6%+23.1%+24.1%+19.6%
Other income3.513.723.432.283.964.543.512.12
Total expenses150138130133122118112114
EBITDA75.6172.6352.3068.9156.5255.6440.2548.79
EBITDA margin+33.5%+34.5%+28.7%+34.1%+31.6%+32.0%+26.4%+29.9%
Depreciation11.2312.9419.589.708.9511.7815.349.94
Interest1.261.43(0.47)0.600.620.600.480.63
Profit before tax66.6361.9836.6260.8950.9147.8027.9440.34
Tax16.4618.4010.4717.8614.8625.858.8410.75
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue774633524486562474401
Revenue growth+17.4%+14.6%+4.5%+12.8%+8.7%+9.3%+25.0%
Other income13.3913.347.185.397.4012.289.42
Total expenses523446389372330304278
Employee cost12811910310358.8256.7945.75
EBITDA251188135114232171123
EBITDA margin+32.5%+29.6%+25.8%+23.5%+41.2%+36.0%+30.8%
Depreciation51.1746.5239.1134.0828.4721.0819.54
Interest3.163.144.884.543.080.661.32
Profit before tax21015198.2281.07207161112
Tax61.5955.4327.0824.1055.3341.5132.68
Net profit14791.4268.8455.24149114104
Net profit margin+19.0%+14.4%+13.1%+11.4%+26.5%+24.1%+25.9%
EPS (₹)9.3518.0813.4410.7628.7422.6515.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital15952.9952.9552.9352.9052.8752.84
Reserves & surplus331430427449468393325
Shareholders' funds (net worth)561537514521521445378
Secured loans0.000.0028.630.000.000.000.00
Unsecured loans48.1823.2110.1921.1721.439.639.20
Total debt48.1823.2138.8221.1721.439.639.20
Total liabilities626572560547542469395
Assets
Gross block409342302279246193167
Net block180158159157149119112
Capital work in progress3.0714.170.760.822.158.283.87
Investments294284291274259274239
Inventories46.5645.7045.6927.0524.2222.1618.49
Sundry debtors69.5368.9440.2083.3192.7844.2915.19
Cash & bank balances62.6351.9834.1016.3912.007.677.30
Loans & advances30.2627.9710.407.4312.974.913.64
Total current assets20919513013414279.0344.62
Total current liabilities85.5610459.7765.3454.8759.2647.08
Net working capital12390.1470.6268.8487.1019.77(2.46)
Total assets626572560547542469395
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash15.183.5612.3711.505.054.884.36
Net cash from operating activities206179155120106111136
Net cash from investing activities(20.92)(42.58)(80.29)(31.65)(12.32)(53.09)26.84
Net cash from financing activities(167)(124)(83.71)(87.50)(86.91)(57.81)(163)
Net change in cash17.7011.62(8.81)0.876.450.170.52
Closing cash62.6351.9834.1016.3912.007.677.30
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+22.3%+20.8%+7.7%-13.4%+18.4%+18.3%+8.3%
EBITDA growth+34.0%+38.9%+18.1%-50.6%+35.6%+38.3%-16.7%
PBT growth+39.1%+54.0%+21.2%-60.9%+28.6%+44.0%-23.7%
Net income growth+60.8%+32.8%+24.6%-62.8%+30.3%+10.0%+12.9%
Revenue CAGR (3Y)+16.8%+4.1%+3.4%+6.7%+14.9%+12.7%+10.5%
EBITDA CAGR (3Y)+30.0%-6.8%-7.5%-2.5%+16.1%+7.7%+12.2%
Profitability & leverage
Net income margin+19.2%+15.1%+13.6%+11.7%+27.1%+25.3%+19.8%
Return on capital employed+35.7%+27.3%+18.6%+15.7%+41.6%+37.5%+35.6%
Return on net worth+27.1%+18.2%+13.8%+10.9%+31.5%+29.1%+24.9%
Debt / equity0.070.060.060.040.030.020.01
Long-term debt / equity0.050.040.040.030.020.010.01
Interest cover1.582.235.095.661.520.441.27
Efficiency & per share
Fixed asset turnover2.061.971.811.852.562.632.57
Inventory turnover16.7813.8514.4118.9824.2123.3323.56
Debtors turnover11.1811.608.495.538.1915.9530.56
EPS (₹)9.3518.0813.4410.7628.7422.6515.01
Dividend per share (₹)14.0021.0018.0018.0015.0025.005.00
Book value per share (₹)30.7991.1990.5894.8698.4384.2671.58
Want more history and ratios?
You're viewing the latest exchange-filed financials for Thyrocare Technologies Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Thyrocare Technologies Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 60.90%, foreign institutional investors hold 5.40%, domestic institutional investors hold 21.00%, retail and other public shareholders hold 12.70% of Thyrocare Technologies Limited.

Promoters: 60.90%DII (Domestic Institutional): 21.00%FII (Foreign Institutional): 5.40%Retail & Others: 12.70%
Jun 2026
QUARTER
60.90% Promoters
21.00% DII (Domestic Institutional)
5.40% FII (Foreign Institutional)
12.70% Retail & Others
Promoter holding - history
Now 60.90% · Jun 2026High 71.10% · Sep 2025Low 60.90% · Dec 2025
59%62.5%66%69.5%73%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 71.10%Dec 2025: 60.90%Mar 2026: 60.90%Jun 2026: 60.90%71.10%60.90%60.90%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters60.90%60.90%60.90%71.10%
Public39.10%39.10%39.10%28.90%

Group Structure of Thyrocare Technologies Limited

Thyrocare Technologies Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Thyrocare Technologies Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Nueclear Healthcare Limited U74120MH2011PLC212839 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Thyrocare Technologies Limited

Open charges
₹0
Satisfied charges
₹45.05 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹45.00 Cr
Uti Bank Ltd;₹0.05 Cr
Latest charge details
DateLenderAmountStatus
29 Apr 2023 Hdfc Bank Limited ₹45 Cr Satisfied
29 Apr 2002 Uti Bank Ltd; ₹4.62 Lakh Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Thyrocare Technologies Limited

Thyrocare Technologies Limited has a workforce of 1,758 employees as of Apr 07, 2024.

Employee count
1,758
Active EPFO establishments
2
Employee growth
-6.09%
Premium access

Employee and EPFO history for Thyrocare Technologies Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Thyrocare Technologies Limited

Premium access

GST registrations and filing compliance for Thyrocare Technologies Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Thyrocare Technologies Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Thyrocare Technologies Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Thyrocare Technologies Limited

Premium access

MSME payment history for Thyrocare Technologies Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Thyrocare Technologies Limited

Premium access

Corporate group structure for Thyrocare Technologies Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Thyrocare Technologies Limited

Premium access

MCA filings and documents for Thyrocare Technologies Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Thyrocare Technologies Limited

Directors
08 May 2026
Uday Patel Kadam was appointed as a Additional Director on 08 May 2026 & has been associated with this company since 4 months 20 days.
Directors
08 May 2026
Gaurav Verma was appointed as a Additional Director on 08 May 2026 & has been associated with this company since 4 months 20 days.
Directors
21 Aug 2025
Vikram Gupta was appointed as a Cfo on 21 Aug 2025 & has been associated with this company since 1 year 1 month.
Activity
31 Jul 2025
Thyrocare Technologies Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Directors
24 Jul 2025
Alok Kumar Jagnani was appointed as a Director on 24 Jul 2025 & has been associated with this company since 1 year 2 months.
Activity
31 Mar 2025
Thyrocare Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.

Recent News on Thyrocare Technologies Limited

Stocks that will see action today: January 23, 2025
23 Jan 2025 · Thehindubusinessline
Thyrocare explores divesting radiology business
18 Sep 2024 · Thehindubusinessline

Frequently Asked Questions about Thyrocare Technologies Limited

Thyrocare Technologies Limited is an active public limited company in the healthcare sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 28 January 2000 (26+ years old) and is registered under CIN L85110MH2000PLC123882. Listed on BSE: 539871 and NSE: THYROCARE. The company has 1,758 employees.

Thyrocare Technologies Limited reported revenue of ₹829.04 Cr for FY 2025-26 (up 20.61% YoY) based on consolidated financials.

The current directors of Thyrocare Technologies Limited are:

The primary industry of Thyrocare Technologies Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes. Thyrocare Technologies Limited is listed on both BSE (code: 539871) and NSE (symbol: THYROCARE).

Thyrocare Technologies Limited can be reached at the registered office: D371 Ttc Industrial Area Midc Turbhe, Navi Mumbai, Maharashtra, India – 400703, or through the website thyrocare.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available